The inactivated mgrB gene and the mcr-1 gene are important mechanisms of colistin resistance in Klebsiella pneumoniae and they are threats to the clinical use of colistin. In this study, mcr-1 gene was cloned into K. pneumoniae strains (XH209 and KP10) and their derived strains (XH209 M and KP10 M), which showed high-level resistance to colistin. The acquisition of the mcr-1 gene led to colistin resistance in XH209 and KP10, but the addition of mcr-1 gene did not cause change of colistin minimum inhibitory concentrations in the XH209 M and KP10 M. In addition, the impact of mcr-1 gene on growth rate showed strain specific in K. pneumoniae. In conclusion, the mcr-1 gene does not cause the same level of colistin resistance as the inactivated mgrB gene in K. pneumoniae. The mcr-1 gene has no effect on colisitin resistance when it coexists with inactivated mgrB gene in K. pneumoniae.
Get full access to this article
View all access options for this article.
References
1.
BialvaeiA.Z., and Samadi KafilH.. 2015. Colistin, mechanisms and prevalence of resistance. Curr. Med. Res. Opin., 31:707–721.
2.
OlaitanA.O., MorandS., and RolainJ.M.. 2014. Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria. Front. Microbiol., 5:643.
3.
CannatelliA., GianiT., D'AndreaM.M., Di PilatoV., ArenaF., ConteV., TryfinopoulouK., VatopoulosA., RossoliniG.M., and GroupC.S.. 2014. MgrB inactivation is a common mechanism of colistin resistance in KPC-producing Klebsiella pneumoniae of clinical origin. Antimicrob. Agents Chemother. 58:5696–5703.
4.
RaetzC.R., ReynoldsC.M., TrentM.S., and BishopR.E.. 2007. Lipid A modification systems in gram-negative bacteria. Annu. Rev. Biochem., 76:295–329.
5.
LiuY.-Y., WangY., WalshT.R., YiL.-X., ZhangR., SpencerJ., DoiY., TianG., DongB., HuangX., YuL.-F., GuD., RenH., ChenX., LvL., HeD., ZhouH., LiangZ., LiuJ.-H., and ShenJ.. 2016. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect. Dis., 16:161–168.
6.
CannatelliA., D'AndreaM.M., GianiT., Di PilatoV., ArenaF., AmbrettiS., GaibaniP., and RossoliniG.M.. 2013. In vivo emergence of colistin resistance in Klebsiella pneumoniae producing KPC-type carbapenemases mediated by insertional inactivation of the PhoQ/PhoP mgrB regulator. Antimicrob. Agents Chemother., 57:5521–5526.
7.
GaoR., HuY., LiZ., SunJ., WangQ., LinJ., YeH., LiuF., SrinivasS., LiD., ZhuB., LiuY.H., TianG.B., and FengY.. 2016. Dissemination and mechanism for the MCR-1 colistin resistance. PLoS Pathog., 12:e1005957.
8.
CasparY., MailletM., PaveseP., FranconyG., BrionJ.P., MallaretM.R., BonnetR., RobinF., BeyrouthyR., and MaurinM.. 2017. mcr-1 Colistin resistance in ESBL-producing Klebsiella pneumoniae, France. Emerg. Infect. Dis., 23:874.
9.
QuanJ., LiX., ChenY., JiangY., ZhouZ., ZhangH., SunL., RuanZ., FengY., AkovaM., and YuY.. 2017. Prevalence of mcr-1 in Escherichia coli and Klebsiella pneumoniae recovered from bloodstream infections in China: a multicentre longitudinal study. Lancet Infect. Dis., 17:400–410.
10.
HuaX., ChenQ., LiX., FengY., RuanZ., and YuY.. 2014. Complete genome sequence of Klebsiella pneumoniae sequence type 17, a multidrug-resistant strain isolated during tigecycline treatment. Genome Announc., 2:e01337–14.
11.
WrightM.S., SuzukiY., JonesM.B., MarshallS.H., RudinS.D., van DuinD., KayeK., JacobsM.R., BonomoR.A., and AdamsM.D.. 2015. Genomic and transcriptomic analyses of colistin-resistant clinical isolates of Klebsiella pneumoniae reveal multiple pathways of resistance. Antimicrob. Agents Chemother., 59:536–543.
12.
ShenP., WeiZ., JiangY., DuX., JiS., YuY., and LiL.. 2009. Novel genetic environment of the carbapenem-hydrolyzing beta-lactamase KPC-2 among Enterobacteriaceae in China. Antimicrob. Agents Chemother., 53:4333–4338.
13.
El-HalfawyO.M., and ValvanoM.A.. 2015. Antimicrobial heteroresistance: an emerging field in need of clarity. Clin. Microbiol. Rev., 28:191–207.
14.
MeletisG., TzampazE., SianouE., TzavarasI., and SofianouD.. 2011. Colistin heteroresistance in carbapenemase-producing Klebsiella pneumoniae. J Antimicrob. Chemother., 66:946–947.
15.
WoottonM., HoweR.A., HillmanR., WalshT.R., BennettP.M., and MacgowanA.P.. 2001. A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital. J. Antimicrob. Chemother., 47:399.
16.
PoirelL., JayolA., BontronS., VillegasM.V., OzdamarM., TurkogluS., and NordmannP.. 2015. The mgrB gene as a key target for acquired resistance to colistin in Klebsiella pneumoniae. J. Antimicrob. Chemother., 70:75–80.
17.
ZhangR., LiuL., ZhouH., ChanE.W., LiJ., FangY., LiY., LiaoK., and ChenS.. 2017. Nationwide surveillance of clinical carbapenem-resistant enterobacteriaceae (CRE) strains in China. EBioMedicine., 19:98–106.
